Dora:  A Phase Ii, Multicenter, International, Non-Comparator Study Of Olaparib (O) +/- Durvalumab (D) As A Chemotherapy-Free Maintenance Strategy In Platinum Treated Advanced Triple-Negative Breast Cancer (Atnbc)
Olaparib;Durvalumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Dora:  A Phase Ii, Multicenter, International, Non-Comparator Study Of Olaparib (O) +/- Durvalumab (D) As A Chemotherapy-Free Maintenance Strategy In Platinum Treated Advanced Triple-Negative Breast Cancer (Atnbc) ### Output: Olaparib;Durvalumab